EVGNEvogene Ltd.
- Market cap
- $4.95M
- as of 2026-10-23
- Latest close
- $0.36
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-08-05
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Falk Dan Michael | Sep 4 | Sep 30 | A · derivative | 2,500 | $0.58 | $1,450 | 2,500 | No | Form 4 |
| Percy Adrian John | Sep 4 | Sep 30 | A · derivative | 2,500 | $0.58 | $1,450 | 2,500 | No | Form 4 |
| Nimrodi Nir | Sep 4 | Sep 30 | A · derivative | 10,000 | $0.58 | $5,800 | 10,000 | No | Form 4 |
| Recanati Leon | Sep 4 | Sep 30 | A · derivative | 2,500 | $0.58 | $1,450 | 2,500 | No | Form 4 |
| Tarcic GabiChief Development Officer | Jun 4 | Aug 26 | P | 1,129 | $0.60 | Purchase +$677 | 1,129 | No | Form 4 |
| Recanati Leon | Aug 11 | Aug 13 | P | 460,000 | $0.64 | Purchase +$294,400 | 1,343,886 | No | Form 4 |
| Recanati Leon | Aug 4 | Aug 5 | P | 800,000 | $0.50 | Purchase +$400,000 | 883,886 | No | Form 4 |